TY - JOUR
T1 - Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis
AU - Chahin, Salim
AU - Miller, Deborah
AU - Sakai, Reiko E.
AU - Wilson, James A.
AU - Frohman, Teresa
AU - Markowitz, Clyde
AU - Jacobs, Dina
AU - Green, Ari
AU - Calabresi, Peter A.
AU - Frohman, Elliot
AU - Galetta, Steven L.
AU - Balcer, Laura J.
N1 - Funding Information:
Peter A. Calabresi has received personal compensation for consulting and serving on scientific advisory boards from; Vertex, Vaccinex, Prothena, and Abbott; and has received research funding from companies; Biogen-IDEC , Medimmune , and Novartis.
Funding Information:
Deborah M. Miller has received consulting fees from Biogen Idec and research support from Teva Neuroscience.
Funding Information:
This investigation was supported, in part, by the National MS Society – American Brain Foundation Clinician Scientist Development Award (Grant number FAN 1757-A-1).
Funding Information:
Ari Green has received Grant support from the NMSS , HHMI , Novartis and NIH .
Publisher Copyright:
©2015 Elsevier B.V.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Background The relation of fatigue in multiple sclerosis (MS) to the visual system, an emerging structural and functional surrogate in MS, has not been well established. Objective We examined how physical and cognitive fatigue could be associated with visual dysfunction and neurologic impairment. Methods At a single time-point, we assessed 143 patients with: Low-contrast letter acuity (LCLA) and high-contrast visual acuity (VA) testing, the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Neuro-Ophthalmic Supplement, the Modified Fatigue Impact Scale (MFIS), the MS Functional Composite (MSFC), and the Expanded Disability Status Scale (EDSS). Results Worse binocular LCLA scores were associated with increased levels of total and physical fatigue (p≤). Greater levels of fatigue were also associated with reduced vision-specific QOL (p;lt). Patients with more physical, but not cognitive, fatigue had greater levels of impairment by the Timed 25-Foot Walk (T25W, r=0.39, p<), 9-Hole Peg Test (9HP r=0.22, p=0.011) and EDSS (r=0.45, p<). Conclusions Reduced vision in MS is highly associated with physical fatigue and could be used to capture more global, difficult to describe, symptoms. The potential differences in physical vs. cognitive fatigue and their correlates may begin to provide insight into their underlying mechanisms.
AB - Background The relation of fatigue in multiple sclerosis (MS) to the visual system, an emerging structural and functional surrogate in MS, has not been well established. Objective We examined how physical and cognitive fatigue could be associated with visual dysfunction and neurologic impairment. Methods At a single time-point, we assessed 143 patients with: Low-contrast letter acuity (LCLA) and high-contrast visual acuity (VA) testing, the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Neuro-Ophthalmic Supplement, the Modified Fatigue Impact Scale (MFIS), the MS Functional Composite (MSFC), and the Expanded Disability Status Scale (EDSS). Results Worse binocular LCLA scores were associated with increased levels of total and physical fatigue (p≤). Greater levels of fatigue were also associated with reduced vision-specific QOL (p;lt). Patients with more physical, but not cognitive, fatigue had greater levels of impairment by the Timed 25-Foot Walk (T25W, r=0.39, p<), 9-Hole Peg Test (9HP r=0.22, p=0.011) and EDSS (r=0.45, p<). Conclusions Reduced vision in MS is highly associated with physical fatigue and could be used to capture more global, difficult to describe, symptoms. The potential differences in physical vs. cognitive fatigue and their correlates may begin to provide insight into their underlying mechanisms.
KW - Disability
KW - Fatigue
KW - Low-contrast acuity
KW - Multiple sclerosis
KW - Quality of life
KW - Vision
UR - http://www.scopus.com/inward/record.url?scp=84937430871&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937430871&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2015.05.005
DO - 10.1016/j.msard.2015.05.005
M3 - Article
C2 - 26195047
AN - SCOPUS:84937430871
SN - 2211-0348
VL - 4
SP - 304
EP - 310
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
IS - 4
ER -